SCHEMBL2017284

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL2024259	0.90	KCNH2 (0.52)	KCNH2PDE3BPDE3AMAPTGAA
	SCHEMBL2016665	0.90	KCNH2 (0.66)	KCNH2MAPTGAAKDM4EMEN1
	SCHEMBL2018593	0.89	KCNH2 (0.50)	KCNH2PDE3BPDE3AMAPTGAA
	SCHEMBL11064312	0.85	PDE3B (0.67)	KCNH2PDE3BPDE3AMAPTGAA
	SCHEMBL23097677	0.83	KCNH2 (0.69)	KCNH2HRH3
	SCHEMBL2018259	0.82	KCNH2 (0.64)	KCNH2MAPTGAAKDM4ENPC1
	SCHEMBL2022360	0.80	GRIN1 (0.56)	KCNH2MAPTGAAKDM4EMEN1
	SCHEMBL2017860	0.78	MEN1 (0.53)	KCNH2PDE3BPDE3AMAPTGAA
	SCHEMBL12233862	0.78	ACHE (0.52)	KCNH2MAPTADAMTS5MEN1KMT2A
	SCHEMBL2017494	0.78	KCNH2 (1.00)	KCNH2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.